A congenital anomaly caused by the failed development of TRUNCUS ARTERIOSUS into separate AORTA and PULMONARY ARTERY. It is characterized by a single arterial trunk that forms the outlet for both HEART VENTRICLES and gives rise to the systemic, pulmonary, and coronary arteries. It is always accompanied by a ventricular septal defect.
The arterial trunk arising from the fetal heart. During development, it divides into AORTA and the PULMONARY ARTERY.
A congenital heart defect characterized by the persistent opening of fetal DUCTUS ARTERIOSUS that connects the PULMONARY ARTERY to the descending aorta (AORTA, DESCENDING) allowing unoxygenated blood to bypass the lung and flow to the PLACENTA. Normally, the ductus is closed shortly after birth.
A fetal blood vessel connecting the pulmonary artery with the descending aorta.
Developmental abnormalities involving structures of the heart. These defects are present at birth but may be discovered later in life.
Radiography of the heart and great vessels after injection of a contrast medium.
Congenital syndrome characterized by a wide spectrum of characteristics including the absence of the THYMUS and PARATHYROID GLANDS resulting in T-cell immunodeficiency, HYPOCALCEMIA, defects in the outflow tract of the heart, and craniofacial anomalies.
Congenital, inherited, or acquired anomalies of the CARDIOVASCULAR SYSTEM, including the HEART and BLOOD VESSELS.
Developmental abnormalities in any portion of the VENTRICULAR SEPTUM resulting in abnormal communications between the two lower chambers of the heart. Classification of ventricular septal defects is based on location of the communication, such as perimembranous, inlet, outlet (infundibular), central muscular, marginal muscular, or apical muscular defect.
'Abnormalities, Multiple' is a broad term referring to the presence of two or more structural or functional anomalies in an individual, which may be genetic or environmental in origin, and can affect various systems and organs of the body.
Flaps of tissue that prevent regurgitation of BLOOD from the HEART VENTRICLES to the HEART ATRIA or from the PULMONARY ARTERIES or AORTA to the ventricles.
A specific pair of GROUP G CHROMOSOMES of the human chromosome classification.
The pathologic narrowing of the orifice of the PULMONARY VALVE. This lesion restricts blood outflow from the RIGHT VENTRICLE to the PULMONARY ARTERY. When the trileaflet valve is fused into an imperforate membrane, the blockage is complete.
The short wide vessel arising from the conus arteriosus of the right ventricle and conveying unaerated blood to the lungs.
An infant during the first month after birth.
The two longitudinal ridges along the PRIMITIVE STREAK appearing near the end of GASTRULATION during development of nervous system (NEURULATION). The ridges are formed by folding of NEURAL PLATE. Between the ridges is a neural groove which deepens as the fold become elevated. When the folds meet at midline, the groove becomes a closed tube, the NEURAL TUBE.
The portion of the descending aorta proceeding from the arch of the aorta and extending to the DIAPHRAGM, eventually connecting to the ABDOMINAL AORTA.
The hollow, muscular organ that maintains the circulation of the blood.
Persons whose profession is to give legal advice and assistance to clients and represent them in legal matters. (American Heritage Dictionary, 3d ed)
Using an INTERNET based personal journal which may consist of reflections, comments, and often hyperlinks.
Mood-stimulating drugs used primarily in the treatment of affective disorders and related conditions. Several MONOAMINE OXIDASE INHIBITORS are useful as antidepressants apparently as a long-term consequence of their modulation of catecholamine levels. The tricyclic compounds useful as antidepressive agents (ANTIDEPRESSIVE AGENTS, TRICYCLIC) also appear to act through brain catecholamine systems. A third group (ANTIDEPRESSIVE AGENTS, SECOND-GENERATION) is a diverse group of drugs including some that act specifically on serotonergic systems.
Substances that contain a fused three-ring moiety and are used in the treatment of depression. These drugs block the uptake of norepinephrine and serotonin into axon terminals and may block some subtypes of serotonin, adrenergic, and histamine receptors. However the mechanism of their antidepressant effects is not clear because the therapeutic effects usually take weeks to develop and may reflect compensatory changes in the central nervous system.
Compounds that specifically inhibit the reuptake of serotonin in the brain.
An affective disorder manifested by either a dysphoric mood or loss of interest or pleasure in usual activities. The mood disturbance is prominent and relatively persistent.
Depressive states usually of moderate intensity in contrast with major depression present in neurotic and psychotic disorders.

Anatomical study of truncus arteriousus communis with embryological and surgical considerations. (1/56)

Twelve specimens of truncus arteriosus communis have been studied anatomically, with special reference to the conal anatomy and to the associated cardiac anomalies which can create additional problems if surgical repair is planned. A wide spectrum of conal morphology has been observed, suggesting that differential conal absorption is a developmental characteristic of truncus arteriousus as well as of transposition complexes. The invariable absence of septation of the ventricular infundibula and semilunar valves, in spite of the variable anatomy of the free wall of the conus, indicates that all types of truncus arteriosus, ontogenetically, should be considered as a single undivided conotruncus. Various types of ventircular septal defect were found: (a) ventricular septal defect with absent crista, in which no remnants of conal septum are present; (b) supracristal ventricular septal defect, in which vestigial conal septum is seen in front of the membranous septum; (c) bulloventricular foramen, associated with univentricular origin of the truncus from the right ventricle. Frequent associated anomalies are underdevelopment of the aortic arch, truncal valve malformations, and obstructive ventricular septal defect. The AV conduction system studied in one case showed an arrangement similar to Fallot's tetralogy with the His bundle and the left bundle-branch in a safe position behind the posteroinferior rim of the defect. The postoperative fate of the frequently abnormal truncal valve and the theoretical indications for total repair for Type IV truncus are also discussed.  (+info)

Eisenmenger syndrome in adults: ventricular septal defect, truncus arteriosus, univentricular heart. (2/56)

OBJECTIVES: Morbidity and mortality patterns were characterized in adults with the Eisenmenger syndrome when two ventricles with a ventricular septal defect (VSD) joined two great arteries or one great artery, or when one ventricle joined two great arteries. BACKGROUND: Although afterload in these disorders differs, clinical differences have not been defined. METHODS: Seventy-seven patients were studied. Group A comprised 47 patients with VSD, aged 23 to 69 years (mean 39.5+/-10.2), follow-up 5 to 18 years (mean 7.2+/-4.9); group B, 14 patients with truncus arteriosus, aged 27 to 50 years (mean 33.7+/-7.3), follow-up 6 to 18 years (mean 7.7+/-5.1), and group C, 16 patients with univentricular heart, aged 18 to 44 years (mean 30.6+/-8.4), follow-up 5 to 15 years (mean 4.4+/-4.2). Echocardiography established the diagnoses and anatomic and hemodynamic features. Data were compiled on tachyarrhythmias, pregnancy, infective endocarditis, noncardiac surgery and the multisystem disorders of cyanotic adults. RESULTS: Thirty-five percent of the patients died. Sixty-three percent of deaths were sudden, and resulted from intrapulmonary hemorrhage, rupture of either the pulmonary trunk, ascending aorta or a bronchial artery, or vasospastic cerebral infarction, or the cause was unestablished. There were no documented tachyarrhythmic sudden deaths. CONCLUSIONS: Medical management of coexisting cardiac disease, multisystem systemic disorders, noncardiac surgery and pregnancy has reduced morbidity. Increased longevity exposed patients to proximal pulmonary arterial aneurysms, thromboses and calcification; to truncal valve stenosis and regurgitation; to semilunar and atrioventricular valve regurgitation, and to major risks of nontachyarrhythmic sudden death.  (+info)

Factors associated with outcomes of persistent truncus arteriosus. (3/56)

OBJECTIVES: The purpose of this study was to identify trends and factors associated with outcomes of persistent truncus arteriosus (PTA). BACKGROUND: Although there have been significant improvements, PTA continues to be associated with significant morbidity and mortality. METHODS: We undertook a review of all consecutive cases of PTA (n = 205) presenting at our institution from 1953 to 1997. Data were collected regarding demographics, anatomy, management (surgical palliation and repair) and outcomes (mortality and reoperation). RESULTS: Significant trends (p < or = 0.001) related to groups defined by year of birth were as follows: number of cases (1953-1967, n = 13; 1968-1977, n = 42; 1978-1987, n = 69; 1988-1997, n = 81), median age at first assessment (8 months, 42 days, 7 days and 2 days, respectively), proportion who did not have any surgery (58%, 27%, 22% and 11%), proportion who had an initial palliative procedure (25%, 37%, 6% and 2%), proportion who underwent PTA repair (31%, 59%, 72% and 88%), median age at PTA repair (11.2 years, 1.1 years, 1.6 months and 12 days) and proportion dying before hospital discharge after repair (50%, 63%, 56% and 41%). Since 1995, mortality before hospital discharge after repair has further decreased to 2/11 (18%). Increasing time to initial conduit replacement in hospital survivors was significantly related to larger sized conduit at repair (p = 0.02) and use of pulmonary homografts (vs. aortic homografts or xenografts; p = 0.002). Interventional catheterization to address conduit obstructions significantly increased conduit longevity. CONCLUSIONS: Significant improvements in PTA outcomes are evident with trends toward earlier age at assessment and complete repair.  (+info)

Reinterventions after repair of common arterial trunk in neonates and young infants. (4/56)

OBJECTIVES: To determine rates of reintervention after repair of common arterial trunk in the neonatal and early infant periods. BACKGROUND: With improving success in the early treatment of common arterial trunk, the need for reinterventional procedures in older children, adolescents and adults will become an increasingly widespread concern in the treatment of these patients. METHODS: We reviewed our experience with 159 infants younger than four months of age who underwent complete primary repair of common arterial trunk at our institution from 1975 to 1998, with a focus on postoperative reinterventions. RESULTS: Of 128 early survivors, 40 underwent early reinterventions for persistent mediastinal bleeding or other reasons. During a median follow-up of 98 months (range, 2 to 235 months), 121 reinterventions were performed in 81 patients. Actuarial freedom from reintervention was 50% at four years, and freedom from a second reintervention was 75% at 11 years. A total of 92 conduit reinterventions were performed in 75 patients, with a single reintervention in 61 patients, 2 reinterventions in 11 patients and 3 reinterventions in 3 patients. Freedom from a first conduit reintervention was 45% at five years. The only independent variable predictive of a longer time to first conduit replacement was use of an allograft conduit at the original repair (p = 0.05), despite the significantly younger age of patients receiving an allograft conduit (p < 0.001). Reintervention on the truncal valve was performed on 22 occasions in 19 patients, including 21 valve replacements in 18 patients and repair in 1, with a freedom from truncal valve reintervention of 83% at 10 years. Surgical (n = 29) or balloon (n = 12) reintervention for pulmonary artery stenosis was performed 41 times in 32 patients. Closure of a residual ventricular septal defect was required in 13 patients, all of whom underwent closure originally with a continuous suture technique. Eight of 16 late deaths were related to reintervention. CONCLUSIONS: The burden of reintervention after repair of common arterial trunk in early infancy is high. Although conduit reintervention is inevitable, efforts should be made at the time of the initial repair to minimize factors leading to reintervention, including prevention of branch pulmonary artery stenosis and residual interventricular communications.  (+info)

Normal fate and altered function of the cardiac neural crest cell lineage in retinoic acid receptor mutant embryos. (5/56)

Mouse embryos lacking the retinoic acid (RA) receptors RARalpha1 and RARbeta suffer from a failure to properly septate (divide) the early outflow tract of the heart into distinct aortic and pulmonary channels, a phenotype termed persistent truncus arteriosus. This phenotype is associated with a failure in the development of the cardiac neural crest cell lineage, which normally forms the aorticopulmonary septum. In this study, we examined the fate of the neural crest lineage in RARalpha1/RARbeta mutant embryos by crossing with the Wnt1-cre and conditional R26R alleles, which together constitute a genetic lineage marker for the neural crest. We find that the number, migration, and terminal fate of the cardiac neural crest is normal in mutant embryos; however, the specific function of these cells in forming the aorticopulmonary septum is impaired. We furthermore show that the neural crest cells themselves do not utilize retinoid receptors and do not respond to RA during this process, but rather that the phenotype is cell non-autonomous for the neural crest cell lineage. This suggests that an alternative tissue in the vicinity of the outflow tract of the heart responds directly to RA, and thereby induces or permits the neural crest cell lineage to initiate aorticopulmonary septation.  (+info)

BMP signaling is required for septation of the outflow tract of the mammalian heart. (6/56)

Bone morphogenetic proteins (BMPs) constitute a family of approximately 20 growth factors involved in a tremendous variety of embryonic inductive processes. BMPs elicit dose-dependent effects on patterning during gastrulation and gradients of BMP activity are thought to be established through regulation of the relative concentrations of BMP receptors, ligands and antagonists. We tested whether later developmental events also are sensitive to reduced levels of BMP signaling. We engineered a knockout mouse that expresses a BMP type II receptor that lacks half of the ligand-binding domain. This altered receptor is expressed at levels comparable with the wild-type allele, but has reduced signaling capability. Unlike Bmpr2-null mice, mice homozygous for this hypomorphic receptor undergo normal gastrulation, providing genetic evidence of the dose-dependent effects of BMPs during mammalian development. Mutants, however, die at midgestation with cardiovascular and skeletal defects, demonstrating that the development of these tissues requires wild-type levels of BMP signaling. The most striking defects occur in the outflow tract of the heart, with absence of septation of the conotruncus below the valve level and interrupted aortic arch, a phenotype known in humans as persistent truncus arteriosus (type A4). In addition, semilunar valves do not form in mutants, while the atrioventricular valves appear unaffected. Abnormal septation of the heart and valve anomalies are the most frequent forms of congenital cardiac defects in humans; however, most mouse models display broad defects throughout cardiac tissues. The more restricted spectrum of cardiac anomalies in Bmpr2(deltaE2) mutants makes this strain a key murine model to understand the embryonic defects of persistent truncus arteriosus and impaired semilunar valve formation in humans.  (+info)

Endocarditis with aneurysm involving an aortic homograft used to correct a truncus arteriosus: medical-surgical salvage. (7/56)

An aneurysm of an aortic homograft conduit, used to correct a type I truncus arteriosus anomaly in a four month old infant, developed when the patient was 15. Blood cultures grew Staphylococcus aureus. The aneurysm was detected by magnetic resonance imaging and digital subtraction angiocardiography. An emergency open heart operation, guided by these investigations, was performed to remove the original homograft and replace it with another valved aortic homograft. Postoperative antibiotic treatment had to be stopped when profound neutropenia developed. This responded to treatment with recombinant human granulocyte colony stimulating factor. Three years later she was symptom free and did not require medication. Chest x rays and echocardiograms showed a normally functioning heart and conduit valve.  (+info)

Rare variant of truncus arteriosus with intact ventricular septum and hypoplastic right ventricle. (8/56)

A three week old girl was admitted to hospital with severe congestive heart failure and cyanosis. Cross sectional and Doppler echocardiography and cardiac catheterisation showed a unique variant of truncus arteriosus with an intact ventricular septum. The trunk rose only from the left ventricle and was associated with a hypoplastic right ventricle with sinusoids to the right coronary artery.  (+info)

Persistent Truncus Arteriosus is a rare congenital heart defect that is characterized by the failure of the truncus arteriosus to divide into the separate pulmonary artery and aorta during fetal development. This results in a single large vessel, the truncus arteriosus, which gives rise to both the systemic and pulmonary circulations.

The truncus arteriosus contains a single semilunar valve, instead of the two separate semilunar valves (pulmonary and aortic) found in a normal heart. Additionally, there is often a ventricular septal defect (VSD), a hole in the wall between the two lower chambers of the heart, present.

This condition leads to mixing of oxygenated and deoxygenated blood within the truncus arteriosus, resulting in cyanosis (bluish discoloration of the skin and mucous membranes) and decreased oxygen delivery to the body. Symptoms typically appear soon after birth and may include difficulty breathing, poor feeding, rapid heart rate, and failure to thrive.

Persistent truncus arteriosus is usually treated with surgical repair in infancy or early childhood to separate the pulmonary and systemic circulations, close the VSD, and reconstruct the great vessels as needed.

Truncus Arteriosus is a congenital heart defect where a single large vessel arises from the heart, instead of separate pulmonary and aortic trunks. This results in the mixing of oxygenated and deoxygenated blood within the truncus. The truncus then divides into systemic, coronary, and pulmonary arteries. It's usually associated with a ventricular septal defect. This condition is often diagnosed early in life due to cyanosis (bluish discoloration of the skin) and heart murmurs. Surgical correction is required for survival.

Patent Ductus Arteriosus (PDA) is a congenital heart defect in which the ductus arteriosus, a normal fetal blood vessel that connects the pulmonary artery and the aorta, fails to close after birth. The ductus arteriosus allows blood to bypass the lungs while the fetus is still in the womb, but it should close shortly after birth as the newborn begins to breathe and oxygenate their own blood.

If the ductus arteriosus remains open or "patent," it can result in abnormal blood flow between the pulmonary artery and aorta. This can lead to various cardiovascular complications, such as:

1. Pulmonary hypertension (high blood pressure in the lungs)
2. Congestive heart failure
3. Increased risk of respiratory infections

The severity of the symptoms and the need for treatment depend on the size of the PDA and the amount of blood flow that is shunted from the aorta to the pulmonary artery. Small PDAs may close on their own over time, while larger PDAs typically require medical intervention, such as medication or surgical closure.

The Ductus Arteriosus is a fetal blood vessel that connects the pulmonary trunk (the artery that carries blood from the heart to the lungs) and the aorta (the largest artery in the body, which carries oxygenated blood from the heart to the rest of the body). This vessel allows most of the blood from the right ventricle of the fetal heart to bypass the lungs, as the fetus receives oxygen through the placenta rather than breathing air.

After birth, with the first breaths, the blood oxygen level increases and the pressure in the lungs rises. As a result, the circulation in the newborn's body changes, and the Ductus Arteriosus is no longer needed. Within the first few days or weeks of life, this vessel usually closes spontaneously, turning into a fibrous cord called the Ligamentum Arteriosum.

Persistent Patency of the Ductus Arteriosus (PDA) occurs when the Ductus Arteriosus does not close after birth, which can lead to various complications such as heart failure and pulmonary hypertension. This condition is often seen in premature infants and may require medical intervention or surgical closure of the vessel.

Congenital heart defects (CHDs) are structural abnormalities in the heart that are present at birth. They can affect any part of the heart's structure, including the walls of the heart, the valves inside the heart, and the major blood vessels that lead to and from the heart.

Congenital heart defects can range from mild to severe and can cause various symptoms depending on the type and severity of the defect. Some common symptoms of CHDs include cyanosis (a bluish tint to the skin, lips, and fingernails), shortness of breath, fatigue, poor feeding, and slow growth in infants and children.

There are many different types of congenital heart defects, including:

1. Septal defects: These are holes in the walls that separate the four chambers of the heart. The two most common septal defects are atrial septal defect (ASD) and ventricular septal defect (VSD).
2. Valve abnormalities: These include narrowed or leaky valves, which can affect blood flow through the heart.
3. Obstruction defects: These occur when blood flow is blocked or restricted due to narrowing or absence of a part of the heart's structure. Examples include pulmonary stenosis and coarctation of the aorta.
4. Cyanotic heart defects: These cause a lack of oxygen in the blood, leading to cyanosis. Examples include tetralogy of Fallot and transposition of the great arteries.

The causes of congenital heart defects are not fully understood, but genetic factors and environmental influences during pregnancy may play a role. Some CHDs can be detected before birth through prenatal testing, while others may not be diagnosed until after birth or later in childhood. Treatment for CHDs may include medication, surgery, or other interventions to improve blood flow and oxygenation of the body's tissues.

Angiocardiography is a medical procedure used to examine the heart and blood vessels, particularly the chambers of the heart and the valves between them. It involves injecting a contrast agent into the bloodstream and taking X-ray images as the agent flows through the heart. This allows doctors to visualize any abnormalities such as blockages, narrowing, or leakage in the heart valves or blood vessels.

There are different types of angiocardiography, including:

* Left heart catheterization (LHC): A thin tube called a catheter is inserted into a vein in the arm or groin and threaded through to the left side of the heart to measure pressure and oxygen levels.
* Right heart catheterization (RHC): Similar to LHC, but the catheter is threaded through to the right side of the heart to measure pressure and oxygen levels there.
* Selective angiocardiography: A catheter is used to inject the contrast agent into specific blood vessels or chambers of the heart to get a more detailed view.

Angiocardiography can help diagnose and evaluate various heart conditions, including congenital heart defects, coronary artery disease, cardiomyopathy, and valvular heart disease. It is an invasive procedure that carries some risks, such as bleeding, infection, and damage to blood vessels or heart tissue. However, it can provide valuable information for diagnosing and treating heart conditions.

DiGeorge syndrome is a genetic disorder caused by the deletion of a small piece of chromosome 22. It is also known as 22q11.2 deletion syndrome. The symptoms and severity can vary widely among affected individuals, but often include birth defects such as congenital heart disease, poor immune system function, and palatal abnormalities. Characteristic facial features, learning disabilities, and behavioral problems are also common. Some people with DiGeorge syndrome may have mild symptoms while others may be more severely affected. The condition is typically diagnosed through genetic testing. Treatment is focused on managing the specific symptoms and may include surgery, medications, and therapy.

Cardiovascular abnormalities refer to structural or functional anomalies in the heart or blood vessels. These abnormalities can be present at birth (congenital) or acquired later in life. They can affect the heart's chambers, valves, walls, or blood vessels, leading to various complications such as heart failure, stroke, or even death if left untreated.

Examples of congenital cardiovascular abnormalities include:

1. Septal defects - holes in the walls separating the heart's chambers (atrial septal defect, ventricular septal defect)
2. Valvular stenosis or insufficiency - narrowing or leakage of the heart valves
3. Patent ductus arteriosus - a persistent opening between the aorta and pulmonary artery
4. Coarctation of the aorta - narrowing of the aorta
5. Tetralogy of Fallot - a combination of four heart defects, including ventricular septal defect, overriding aorta, pulmonary stenosis, and right ventricular hypertrophy

Examples of acquired cardiovascular abnormalities include:

1. Atherosclerosis - the buildup of plaque in the arteries, leading to narrowing or blockage
2. Cardiomyopathy - disease of the heart muscle, causing it to become enlarged, thickened, or stiffened
3. Hypertension - high blood pressure, which can damage the heart and blood vessels over time
4. Myocardial infarction (heart attack) - damage to the heart muscle due to blocked blood supply
5. Infective endocarditis - infection of the inner lining of the heart chambers and valves

These abnormalities can be diagnosed through various tests, such as echocardiography, electrocardiogram (ECG), stress testing, cardiac catheterization, or magnetic resonance imaging (MRI). Treatment options depend on the type and severity of the abnormality and may include medications, medical procedures, or surgery.

A ventricular septal defect (VSD) is a type of congenital heart defect that involves a hole in the wall separating the two lower chambers of the heart, the ventricles. This defect allows oxygenated blood from the left ventricle to mix with deoxygenated blood in the right ventricle, leading to inefficient oxygenation of the body's tissues. The size and location of the hole can vary, and symptoms may range from none to severe, depending on the size of the defect and the amount of blood that is able to shunt between the ventricles. Small VSDs may close on their own over time, while larger defects usually require medical intervention, such as medication or surgery, to prevent complications like pulmonary hypertension and heart failure.

'Abnormalities, Multiple' is a broad term that refers to the presence of two or more structural or functional anomalies in an individual. These abnormalities can be present at birth (congenital) or can develop later in life (acquired). They can affect various organs and systems of the body and can vary greatly in severity and impact on a person's health and well-being.

Multiple abnormalities can occur due to genetic factors, environmental influences, or a combination of both. Chromosomal abnormalities, gene mutations, exposure to teratogens (substances that cause birth defects), and maternal infections during pregnancy are some of the common causes of multiple congenital abnormalities.

Examples of multiple congenital abnormalities include Down syndrome, Turner syndrome, and VATER/VACTERL association. Acquired multiple abnormalities can result from conditions such as trauma, infection, degenerative diseases, or cancer.

The medical evaluation and management of individuals with multiple abnormalities depend on the specific abnormalities present and their impact on the individual's health and functioning. A multidisciplinary team of healthcare professionals is often involved in the care of these individuals to address their complex needs.

Heart valves are specialized structures in the heart that ensure unidirectional flow of blood through its chambers during the cardiac cycle. There are four heart valves: the tricuspid valve and the mitral (bicuspid) valve, located between the atria and ventricles, and the pulmonic (pulmonary) valve and aortic valve, located between the ventricles and the major blood vessels leaving the heart.

The heart valves are composed of thin flaps of tissue called leaflets or cusps, which are supported by a fibrous ring. The aortic and pulmonic valves have three cusps each, while the tricuspid and mitral valves have three and two cusps, respectively.

The heart valves open and close in response to pressure differences across them, allowing blood to flow forward into the ventricles during diastole (filling phase) and preventing backflow of blood into the atria during systole (contraction phase). A properly functioning heart valve ensures efficient pumping of blood by the heart and maintains normal blood circulation throughout the body.

Human chromosome pair 22 consists of two rod-shaped structures present in the nucleus of each cell in the human body. Each chromosome is made up of DNA tightly coiled around histone proteins, forming a complex structure called a chromatin.

Chromosome pair 22 is one of the 22 autosomal pairs of human chromosomes, meaning they are not sex chromosomes (X or Y). Chromosome 22 is the second smallest human chromosome, with each arm of the chromosome designated as p and q. The short arm is labeled "p," and the long arm is labeled "q."

Chromosome 22 contains several genes that are associated with various genetic disorders, including DiGeorge syndrome, velocardiofacial syndrome, and cat-eye syndrome, which result from deletions or duplications of specific regions on the chromosome. Additionally, chromosome 22 is the location of the NRXN1 gene, which has been associated with an increased risk for autism spectrum disorder (ASD) and schizophrenia when deleted or disrupted.

Understanding the genetic makeup of human chromosome pair 22 can provide valuable insights into human genetics, evolution, and disease susceptibility, as well as inform medical diagnoses, treatments, and research.

Pulmonary Valve Stenosis is a cardiac condition where the pulmonary valve, located between the right ventricle and the pulmonary artery, has a narrowed opening. This stenosis (narrowing) can cause obstruction of blood flow from the right ventricle to the lungs. The narrowing can be caused by a fusion of the valve leaflets, thickened or calcified valve leaflets, or rarely, a dysplastic valve.

The severity of Pulmonary Valve Stenosis is classified based on the gradient pressure across the valve, which is measured during an echocardiogram. A mild stenosis has a gradient of less than 30 mmHg, moderate stenosis has a gradient between 30-59 mmHg, and severe stenosis has a gradient of 60 mmHg or higher.

Mild Pulmonary Valve Stenosis may not require treatment, while more severe cases may need to be treated with balloon valvuloplasty or surgical valve replacement. If left untreated, Pulmonary Valve Stenosis can lead to right ventricular hypertrophy, heart failure, and other complications.

The pulmonary artery is a large blood vessel that carries deoxygenated blood from the right ventricle of the heart to the lungs for oxygenation. It divides into two main branches, the right and left pulmonary arteries, which further divide into smaller vessels called arterioles, and then into a vast network of capillaries in the lungs where gas exchange occurs. The thin walls of these capillaries allow oxygen to diffuse into the blood and carbon dioxide to diffuse out, making the blood oxygen-rich before it is pumped back to the left side of the heart through the pulmonary veins. This process is crucial for maintaining proper oxygenation of the body's tissues and organs.

A newborn infant is a baby who is within the first 28 days of life. This period is also referred to as the neonatal period. Newborns require specialized care and attention due to their immature bodily systems and increased vulnerability to various health issues. They are closely monitored for signs of well-being, growth, and development during this critical time.

The neural crest is a transient, multipotent embryonic cell population that originates from the ectoderm (outermost layer) of the developing neural tube (precursor to the central nervous system). These cells undergo an epithelial-to-mesenchymal transition and migrate throughout the embryo, giving rise to a diverse array of cell types and structures.

Neural crest cells differentiate into various tissues, including:

1. Peripheral nervous system (PNS) components: sensory neurons, sympathetic and parasympathetic ganglia, and glial cells (e.g., Schwann cells).
2. Facial bones and cartilage, as well as connective tissue of the skull.
3. Melanocytes, which are pigment-producing cells in the skin.
4. Smooth muscle cells in major blood vessels, heart, gastrointestinal tract, and other organs.
5. Secretory cells in endocrine glands (e.g., chromaffin cells of the adrenal medulla).
6. Parts of the eye, such as the cornea and iris stroma.
7. Dental tissues, including dentin, cementum, and dental pulp.

Due to their wide-ranging contributions to various tissues and organs, neural crest cells play a crucial role in embryonic development and organogenesis. Abnormalities in neural crest cell migration or differentiation can lead to several congenital disorders, such as neurocristopathies.

The thoracic aorta is the segment of the largest artery in the human body (the aorta) that runs through the chest region (thorax). The thoracic aorta begins at the aortic arch, where it branches off from the ascending aorta, and extends down to the diaphragm, where it becomes the abdominal aorta.

The thoracic aorta is divided into three parts: the ascending aorta, the aortic arch, and the descending aorta. The ascending aorta rises from the left ventricle of the heart and is about 2 inches (5 centimeters) long. The aortic arch curves backward and to the left, giving rise to the brachiocephalic trunk, the left common carotid artery, and the left subclavian artery. The descending thoracic aorta runs downward through the chest, passing through the diaphragm to become the abdominal aorta.

The thoracic aorta supplies oxygenated blood to the upper body, including the head, neck, arms, and chest. It plays a critical role in maintaining blood flow and pressure throughout the body.

In medical terms, the heart is a muscular organ located in the thoracic cavity that functions as a pump to circulate blood throughout the body. It's responsible for delivering oxygen and nutrients to the tissues and removing carbon dioxide and other wastes. The human heart is divided into four chambers: two atria on the top and two ventricles on the bottom. The right side of the heart receives deoxygenated blood from the body and pumps it to the lungs, while the left side receives oxygenated blood from the lungs and pumps it out to the rest of the body. The heart's rhythmic contractions and relaxations are regulated by a complex electrical conduction system.

I'm sorry for any confusion, but "Lawyers" is not a term that has a medical definition. The term "Lawyer" refers to a person who is qualified and authorized to practice law in a court of law. They offer advice on legal matters and represent clients in court or in other legal proceedings. If you have any questions about medical terminology, I would be happy to help!

I am not a medical professional, but I can tell you that there is no specific medical definition for "blogging." Blogging is a general term used to describe the act of creating and maintaining a blog or weblog. A blog is a website that contains regularly updated entries, typically written in an informal or conversational style.

Blogging has become a popular way for people to share their thoughts, experiences, and expertise on various topics, including health and wellness. Some healthcare professionals also use blogs as a platform to provide medical information, advice, and updates to their patients and the general public. However, it is essential to note that any medical information obtained from blogs should not replace professional medical advice, diagnosis, or treatment.

Antidepressive agents are a class of medications used to treat various forms of depression and anxiety disorders. They act on neurotransmitters, the chemical messengers in the brain, to restore the balance that has been disrupted by mental illness. The most commonly prescribed types of antidepressants include selective serotonin reuptake inhibitors (SSRIs), serotonin and norepinephrine reuptake inhibitors (SNRIs), tricyclic antidepressants (TCAs), and monoamine oxidase inhibitors (MAOIs). These medications can help alleviate symptoms such as low mood, loss of interest in activities, changes in appetite and sleep patterns, fatigue, difficulty concentrating, and thoughts of death or suicide. It is important to note that antidepressants may take several weeks to reach their full effectiveness and may cause side effects, so it is essential to work closely with a healthcare provider to find the right medication and dosage.

Tricyclic antidepressants (TCAs) are a class of medications that were commonly used to treat depression. The name "tricyclic" comes from the chemical structure of these drugs, which contain three rings in their molecular makeup. TCAs were first developed in the 1950s and remained a popular choice for treating depression until the introduction of selective serotonin reuptake inhibitors (SSRIs) in the late 1980s.

TCAs work by increasing the levels of neurotransmitters, such as serotonin and norepinephrine, in the brain. Neurotransmitters are chemical messengers that transmit signals between nerve cells. By increasing the levels of these neurotransmitters, TCAs can help to improve mood and alleviate symptoms of depression.

Some common examples of tricyclic antidepressants include amitriptyline, imipramine, and nortriptyline. While TCAs are effective in treating depression, they can have significant side effects, including dry mouth, blurred vision, constipation, and drowsiness. In addition, TCAs can be dangerous in overdose and may increase the risk of suicide in some individuals. As a result, they are typically used as a last resort when other treatments have failed.

Overall, tricyclic antidepressants are a class of medications that were commonly used to treat depression but have largely been replaced by newer drugs due to their side effects and potential risks.

Serotonin uptake inhibitors (also known as Selective Serotonin Reuptake Inhibitors or SSRIs) are a class of medications primarily used to treat depression and anxiety disorders. They work by increasing the levels of serotonin, a neurotransmitter in the brain that helps regulate mood, appetite, and sleep, among other functions.

SSRIs block the reuptake of serotonin into the presynaptic neuron, allowing more serotonin to be available in the synapse (the space between two neurons) for binding to postsynaptic receptors. This results in increased serotonergic neurotransmission and improved mood regulation.

Examples of SSRIs include fluoxetine (Prozac), sertraline (Zoloft), paroxetine (Paxil), citalopram (Celexa), and escitalopram (Lexapro). These medications are generally well-tolerated, with side effects that may include nausea, headache, insomnia, sexual dysfunction, and increased anxiety or agitation. However, they can have serious interactions with other medications, so it is important to inform your healthcare provider of all medications you are taking before starting an SSRI.

A depressive disorder is a mental health condition characterized by persistent feelings of sadness, hopelessness, and loss of interest or pleasure in activities. It can also include changes in sleep, appetite, energy levels, concentration, and self-esteem, as well as thoughts of death or suicide. Depressive disorders can vary in severity and duration, with some people experiencing mild and occasional symptoms, while others may have severe and chronic symptoms that interfere with their ability to function in daily life.

There are several types of depressive disorders, including major depressive disorder (MDD), persistent depressive disorder (PDD), and postpartum depression. MDD is characterized by symptoms that interfere significantly with a person's ability to function and last for at least two weeks, while PDD involves chronic low-grade depression that lasts for two years or more. Postpartum depression occurs in women after childbirth and can range from mild to severe.

Depressive disorders are thought to be caused by a combination of genetic, biological, environmental, and psychological factors. Treatment typically involves a combination of medication, psychotherapy (talk therapy), and lifestyle changes.

Depression is a mood disorder that is characterized by persistent feelings of sadness, hopelessness, and loss of interest in activities. It can also cause significant changes in sleep, appetite, energy level, concentration, and behavior. Depression can interfere with daily life and normal functioning, and it can increase the risk of suicide and other mental health disorders. The exact cause of depression is not known, but it is believed to be related to a combination of genetic, biological, environmental, and psychological factors. There are several types of depression, including major depressive disorder, persistent depressive disorder, postpartum depression, and seasonal affective disorder. Treatment for depression typically involves a combination of medication and psychotherapy.

... (PTA), often referred to simply as truncus arteriosus, is a rare form of congenital heart disease ... Persistent truncus arteriosus: a classification according to anatomic types. Surg Clin North Am 1949; 29: 1245-70. "Persistent ... Persistent truncus arteriosus is a rare cardiac abnormality that has a prevalence of less than 1%. Diagrams to illustrate the ... Franz T (1989). "Persistent truncus arteriosus in the Splotch mutant mouse". Anatomy and Embryology. 180 (5): 457-64. doi: ...
Golberg, M.; Heitzman, G.; Kass, I.; Grow, J. B.; Hoffman, M. S. (1957-12-01). "Persistent truncus arteriosus; an unusual type ...
Persistent truncus arteriosus is when the truncus arteriosus fails to split into the aorta and pulmonary trunk. This occurs in ... "Persistent Truncus Arteriosus - Pediatrics". MSD Manual Professional Edition. Retrieved 2022-06-19. Cleveland Clinic (September ... persistent truncus arteriosus, and Ebstein's anomaly are various congenital cyanotic heart diseases, in which the blood of the ... "Truncus Arteriosus". Cleveland Clinic. Archived from the original on 2020-08-04. Bhat, Venkatraman (2016). "Illustrated Imaging ...
AMH Persistent Mullerian duct syndrome, type II; 261550; AMHR2 Persistent truncus arteriosus; 217095; NKX2-6 Peters anomaly; ... persistent, autosomal dominant, due to methionine adenosyltransferase I/III deficiency; 250850; MAT1A Hyperornithinemia- ... DCTN1 Persistent Mullerian duct syndrome, type I; 261550; ...
Such defects include persistent truncus arteriosus, total anomalous pulmonary venous connection, tetralogy of Fallot, ... If the separation is incomplete, the result is a "persistent truncus arteriosus". The vessels may be reversed ("transposition ... Mitral stenosis Myocardial bridge Persistent truncus arteriosus Pulmonary atresia Pulmonary stenosis Rhabdomyomas (Tumors of ... Less common defects in the association are truncus arteriosus and transposition of the great arteries.[citation needed] The ...
Persistent truncus arteriosus - Defect in that the truncus arteriosus fails to divide. Pulmonary valve stenosis (PVS) - ... Patent ductus arteriosus (PDA) - Failure of the ductus arteriosus to close on birth. Patent foramen ovale (PFO) - An atrial ...
A failure of the aorticopulmonary septum to divide the great vessels results in persistent truncus arteriosus. The aorta is an ... 188 In patent ductus arteriosus, a congenital disorder, the fetal ductus arteriosus fails to close, leaving an open vessel ... MedlinePlus > Patent ductus arteriosus Update Date: 21 December 2009 Seeley, Rod; Stephens, Trent; Philip Tate (1992). "20". In ... which loops under the aortic arch just lateral to the ligamentum arteriosum. It then runs back to the neck. The aortic arch has ...
Porter I, Vacek J (May 2008). "Single ventricle with persistent truncus arteriosus as two rare entities in an adult patient: a ...
In embryos containing persistent truncus arteriosus, there is a significant 2-fold reduction in calcium currents, thereby ... These anomalies include persistent truncus arteriosus (PTA), double outlet right ventricle (DORV), tetralogy of Fallot and ... There is no visible difference in the pulmonary veins of chick embryos that developed persistent truncus arteriosus and embryos ... Complete removal of cardiac neural crests results in persistent truncus arteriosus characterised in most cases by the presence ...
The truncus arteriosus is a type of congenital heart disease which was object of study by Rastelli. It is characterized by a ... "Surgical repair of the complete form of persistent common atrioventricular canal". The Journal of Thoracic and Cardiovascular ... D.C. McGoon, G.C. Rastelli, P.A. Ongley, An Operation for the Correction of Truncus Arteriosus, JAMA 1968 Lo Russo, Lucertini, ... McGoon, Dwight C. (8 July 1968). "An Operation for the Correction of Truncus Arteriosus". JAMA: The Journal of the American ...
... atrial septal defects or persistent truncus arteriosus. Other alterations described are craniofacial anomalies associated with ... Axenfeld-Rieger syndrome associated with truncus arteriosus: a case report. Turk J Pediatr 2007;49:444e7 Jena AK, Kharbanda OP ... "Case of chromosome 6p25 terminal deletion associated with Axenfeld-Rieger syndrome and persistent hyperplastic primary vitreous ...
... a fully formed heart Failure of the truncus arteriosus to close results in the condition known as persistent truncus arteriosus ... The truncus arteriosus and bulbus cordis are divided by the aorticopulmonary septum. The truncus arteriosus gives rise to the ... ISBN 978-0-07-163340-6. "Truncus Arteriosus , Pediatric Echocardiography". "Truncus Arteriosus Imaging: Overview, Radiography, ... which takes a spiral course toward the proximal end of the truncus arteriosus. It divides the distal part of the truncus into ...
... or persistent truncus arteriosus. PPVI can also be used to replace dysfunctional artificial heart valves. For those ...
Misalignment of the septum can cause the congenital heart conditions tetralogy of Fallot, persistent truncus arteriosus, dextro ... which takes a spiral course toward the proximal end of the truncus arteriosus. It divides the distal part of the truncus into ... In the developing heart, the truncus arteriosus and bulbus cordis are divided by the aortic septum. This makes its appearance ... Four endocardial cushions appear in the proximal part of the truncus arteriosus in the region of the future semilunar valves; ...
Truncus arteriosus (Persistent) Tricuspid atresia Interrupted aortic arch Coarctation of aorta Pulmonary atresia (PA) Pulmonary ... stenosis (critical) Atrial septal defect Ventricular septal defect Patent ductus arteriosus and Coarctation of aorta (may cause ...
... cortex peristalsis peritoneal cavity peritoneum periventricular nucleus peroneal artery Persistent truncus arteriosus pes ... of humerus Trochlea of superior oblique trochlear nerve trochlear nucleus Trochlear process true vocal cords Truncus arteriosus ... palpebrae superioris levator scapulae muscle levator velum palatini muscle ligament ligament of Treitz ligamentum arteriosum ...
... persistent truncus arteriosus (34%), tetralogy of Fallot, and ventricular septal defect) Cyanosis (bluish skin due to poor ... truncus arteriosus and tetralogy of Fallot) Abnormal facies Thymic aplasia or hypoplasia Cleft palate Hypocalcemia/ ...
... may refer to: Persistent truncus arteriosus, a rare congenital heart disease Truncus arteriosus (embryology), part of ... truncus coeliacus) Brachiocephalic artery (truncus brachiocephalicus) Trunk (anatomy) (truncus) Truncus (mathematics), a ... truncus lumbosacralis) Costocervical trunk (truncus costocervicalis) Sympathetic trunk (truncus Sympaticus) Celiac artery ( ... particular algebraic curve This disambiguation page lists articles associated with the title Truncus. If an internal link led ...
... and causes persistent truncus arteriosus, unequal division of the truncus arteriosus, transposition of the great arteries, ... The truncus arteriosus and the adjacent bulbus cordis partition by means of cells from the neural crest. Once the cells from ... the first one and closest to the arterial end is the truncus arteriosus, then follow the bulbus cordis, the primitive ventricle ... Defects in producing the AV septum produces atrioventricular septal defects, including a persistent AV canal and tricuspid ...
Truncus arteriosus (Persistent) Tricuspid atresia Interrupted aortic arch Pulmonary atresia (PA) Pulmonary stenosis (critical) ... Prophylactic: Propranolol/Inderall Prostaglandin E (to keep the ductus arteriosus patent) Prophylactic antibiotic to prevent ...
Congenital defects can lead to right-to-left shunting immediately after birth: Persistent truncus arteriosus (minimal cyanosis ... Persistent truncus arteriosus (minimal cyanosis) 2 Vessels involved: Transposition of great vessels 3 Leaflets: Tricuspid ... This is seen in Ventricular septal defect, Atrial septal defect, and patent ductus arteriosus, and can manifest as late as ...
... arteriosus Perinatal asphyxia Periventricular leukomalacia Persistent pulmonary hypertension of the newborn Persistent truncus ... arteriosus Pulmonary hypoplasia Retinopathy of prematurity Spina bifida Spinal muscular atrophy Supraventricular tachycardia ...
... truncus arteriosus, persistent MeSH C16.131.240.670 - pulmonary atresia MeSH C16.131.240.700 - scimitar syndrome MeSH C16.131. ... ductus arteriosus, patent MeSH C16.131.240.400.395 - Ebstein's anomaly MeSH C16.131.240.400.450 - Eisenmenger complex MeSH ... persistent hyperinsulinemia hypoglycemia of infancy MeSH C16.320.565.202.810 - pyruvate metabolism, inborn errors MeSH C16.320. ...
... persistent truncus arteriosus with aortopulmonary window that affects the aortic arch, left-to-right shunts, anomalous right ...
Müllerian duct syndrome Persistent parvovirus infection Persistent sexual arousal syndrome Persistent truncus arteriosus ... tarsal synostosis Patella hypoplasia mental retardation Patent ductus arteriosus familial Patent ductus arteriosus Patterson- ... Perniola-Krajewska-Carnevale syndromme Perniosis Peroxisomal Bifunctional Enzyme Deficiency Peroxisomal defects Persistent ...
... surgical procedure Peritonsillar abscess Persistent truncus arteriosus, congenital heart disease Pharmacy Technical Assistant ...
Persistent Truncus Arteriosus, Aortopulmonary Septal Defect, and Hemitruncus Arteriosus", Neonatal Heart Disease, London: ...
... truncus arteriosus, persistent MeSH C14.280.067.093 - arrhythmia, sinus MeSH C14.280.067.198 - atrial fibrillation MeSH C14.280 ... truncus arteriosus, persistent MeSH C14.280.434.160 - cardiomyopathy, dilated MeSH C14.280.434.313 - dyspnea, paroxysmal MeSH ... ductus arteriosus, patent MeSH C14.240.400.395 - Ebstein's anomaly MeSH C14.240.400.450 - Eisenmenger complex MeSH C14.240. ... ductus arteriosus, patent MeSH C14.280.400.395 - Ebstein's anomaly MeSH C14.280.400.450 - Eisenmenger complex MeSH C14.280. ...
Fetal circulation does not include the lungs, which are bypassed via the truncus arteriosus. Before birth the fetus obtains ... Cardiovascular diseases may also be congenital in nature, such as heart defects or persistent fetal circulation, where the ... The blood from the right chamber must flow through the vena arteriosa (pulmonary artery) to the lungs, spread through its ...
Persistent truncus arteriosus (PTA), often referred to simply as truncus arteriosus, is a rare form of congenital heart disease ... Persistent truncus arteriosus: a classification according to anatomic types. Surg Clin North Am 1949; 29: 1245-70. "Persistent ... Persistent truncus arteriosus is a rare cardiac abnormality that has a prevalence of less than 1%. Diagrams to illustrate the ... Franz T (1989). "Persistent truncus arteriosus in the Splotch mutant mouse". Anatomy and Embryology. 180 (5): 457-64. doi: ...
Truncus Arteriosus Cincinnati Childrens Medical Center. *Truncus Arteriosus information from Seattle Childrens Hospital Heart ... Differentiating Persistent truncus arteriosus from other Disorders. Epidemiology and demographics. Risk Factors. Screening. ... Synonyms and Keywords: Truncus arteriosus, TA, Buchanans Syndrome, common arterial trunk, common aortico-pulmonary trunk ... Retrieved from "https://www.wikidoc.org/index.php?title=Persistent_truncus_arteriosus&oldid=1605091" ...
Persistent truncus arteriosus (PTA), which is often referred to simply as TA, is a rare congenital heart disease. A TA is an ... Persistent truncus arteriosus: a rare finding in adults. European Heart Journal, Volume 30, Issue 9, May 2009, Page 1154. doi. ... Surgery for Truncus Arteriosus: Contemporary Practice. Ann Thorac Surg 2021;111:1442-50. ... compatible with truncus arteriosus (TA) Collett & Edwards type I or Van Praagh type A1. The MPA, originating from the left ...
Persistent Truncus Arteriosus - Etiology, pathophysiology, symptoms, signs, diagnosis & prognosis from the MSD Manuals - ... In persistent truncus arteriosus, the primitive truncus does not divide into the pulmonary artery and aorta, resulting in a ... Persistent truncus arteriosus occurs when, during fetal development, the primitive truncus does not divide into the pulmonary ... Persistent Truncus Arteriosus By Lee B. Beerman , MD, Childrens Hospital of Pittsburgh of the University of Pittsburgh School ...
Atrioventricular dissociation in a cat with persistent truncus arteriosus * Monge-Utrilla, O. ...
Truncus arteriosus (TA) is an uncommon congenital cardiovascular anomaly that is characterized by a single arterial trunk ... Pathogenesis of persistent truncus arteriosus in light of observations made in a dog embryo with the anomaly. Am J Cardiol. ... Truncus arteriosus is a congenital anomaly that is present from early in embryonic gestation. Currently, truncus arteriosus is ... encoded search term (Truncus Arteriosus) and Truncus Arteriosus What to Read Next on Medscape ...
Other terms for the condition are (persistent) truncus arteriosus.. The anatomy of common truncus varies, especially in the ... Q20.0 Common truncus. Exclusions. Pulmonary atresia with ventricular septal defect (common truncus type IV in the Edwards ... Common Truncus - Documentation Checklist. Describe in detail the clinical and echocardiographic findings: *Anatomy - specify ... Common truncus or common arterial trunk is a structural heart defect characterized anatomically by having a single common ...
4 Sharma A, Priya S, Jagia P. Persistent truncus arteriosus on dual source CT. Jpn J Radiol 2016; 34 (07) 486-493 ... Truncus arteriosus with sinusal origin of pulmonary artery segment is a rare preoperative diagnosis, limited to few case ... Sinusal variant of truncus arteriosus is a rare preoperative diagnosis. Present case describes an unusual pulmonary arterial ... 2 Sharma A, Pandey NN, Kumar S. Atypical variant of truncus arteriosus: sinusal origin of pulmonary artery segment with non- ...
Persistent Truncus Arteriosus Medicine and Dentistry 56% * Dobutamine Medicine and Dentistry 49% ...
Persistent Truncus Arteriosus 100% * Infant 100% * Surgical Risk 100% * Brain Growth 100% ...
Persistent truncus arteriosus (PTA) describes a morphological defect in which outflow tract fails to septate into two discrete ... including persistent truncus arteriosus, double outlet right ventricle and tetralogy of Fallot. However, the role of the neural ... The cardiac truncus arteriosus is the embryonic precursor to the great arteries, the ascending aorta and the pulmonary artery. ... Originating as a single vessel emerging from the embryonic heart, the truncus arteriosus must septate and remodel into the ...
persistent truncus arteriosis. perinatal lethality, complete penetrance. absent adrenal gland. abnormal cardiac neural crest ...
persistent truncus arteriosis. perinatal lethality, complete penetrance. absent adrenal gland. abnormal cardiac neural crest ...
A major role is served by Pbx1, whose inactivation results in persistent truncus arteriosus. Reduction or absence of Pbx2 or ...
Cardiac anomalies (i.e. tetralogy of fallot, transposition of the great arteries, truncus arteriosus, total anomalous pulmonary ... Persistent pulmonary hypertension of the newborn. *Pulmonary anomalies (i.e., pulmonary arteriovenous malformation) ...
Persistent truncus arteriosus and unrestricted pulmonary blood flow: All patients develop severe pulmonary hypertension by the ... Increased pulmonary arterial pressure and flow: Large VSD, large PDA, truncus arteriosus, single ventricle with unobstructed ... 13] Onset of the syndrome is usually earlier (infancy) in patients with VSD or patent ductus arteriosus (PDA), whereas it tends ... This computed tomography (CT) chest scan shows a large, unrestricted patent ductus arteriosus (PDA) in a 24-year-old woman with ...
Persistent Truncus Arteriosus 100% * Cardiac Care 100% * Young Adult 100% * Follow up 50% ...
Persistent truncus arteriosus. Overview. * Definition: underdevelopment of the aorticopulmonary septum → failure of the truncus ... Coronary arteries in truncus arteriosus. . Am J Cardiol. 1990. ; 66. (20). : p.1482-1486. .doi:. 10.1016/0002-9149(90)90539-d. ... Neonatal repair of truncus arteriosus: continuing improvement in outcomes. . Ann Thorac Surg. 2001. ; 72. (2). : p.391-395. . ... Neonatal truncus arteriosus repair: Surgical techniques and clinical management. . Semin Thorac Cardiovasc Surg Pediatr Card ...
... phenocopying the human heart defect persistent truncus arteriosus, and that trunk neural crest fails to rescue this phenotype. ...
Persistent Truncus Arteriosus 100% * Anticoagulant Therapy 100% * Surgery 75% * Thromboprophylaxis 75% * Child 50% ...
Truncus arteriosus (TA) is an uncommon congenital cardiovascular anomaly that is characterized by a single arterial trunk ... Pathogenesis of persistent truncus arteriosus in light of observations made in a dog embryo with the anomaly. Am J Cardiol. ... Truncus arteriosus is a congenital anomaly that is present from early in embryonic gestation. Currently, truncus arteriosus is ... encoded search term (Truncus Arteriosus) and Truncus Arteriosus What to Read Next on Medscape ...
... including double-outlet right ventricle with ventricular septal defect and persistent truncus arteriosus (Supplemental Table 3 ... in myosin heavy chain 11 cause a syndrome associating thoracic aortic aneurysm/aortic dissection and patent ductus arteriosus. ...
Persistent truncus arteriosus. *Aortopulmonary window. Atrial septal defect. *Sinus venosus atrial septal defect ...
Truncus Arteriosus. • Double Inlet Left Ventricle. • Double Aortic Arch. PPHN is diagnosed right after birth, and it is a ...
Common truncus arteriosus Active Synonym false false 102980010 Persistent truncus arteriosus Active Synonym false false ... Truncus arteriosus communis Active Synonym false false 2899850018 Common arterial trunk (truncus arteriosus) Active Synonym ... Common truncus arteriosus (disorder). Code System Preferred Concept Name. Common truncus arteriosus (disorder). ...
Persistent truncus arteriosus From NCATS Genetic and Rare Diseases Information Center. * A novel GATA6 mutation in patients ...
Persistent truncus arteriosus - Double outlet right ventricle (Taussig-Bing syndrome) - Transposition of the great vessels ( ... Pseudohermaphroditism · True hermaphroditism · Mixed gonadal dysgenesis · Swyer syndrome · Persistent Mullerian duct syndrome ... aorta (Patent ductus arteriosus, Aortic coarctation, Interrupted aortic arch, Overriding aorta, Aneurysm of sinus of Valsalva, ... Persistent left superior vena cava - Total anomalous pulmonary venous connection - Scimitar syndrome ...
Persistent Truncus Arteriosus. Common Arterial Trunk. Single Trunk Emerges from Both Ventricles. Symptoms. Cyanosis. Pulmonary ... Truncus Arteriosus. Transposition of the Great Vessels. Tricuspid Atresia. Tetralogy of Fallot. Total Anomalous Pulmonary ... Persistent ST Elevations in Leads V1-V2. Risk of VTACH and Sudden Cardiac Death. Syncope. Management. ICD. Antiarrhythmics. ...
Coarctation of the Aorta • Truncus Arteriosus • Tricuspid Valve Stenosis • Heart Murmur • Persistent Pulmonary Hypertension of ... Tricuspid Atresia • Aortic Stenosis • Pulmonary Atresia • Patent Ductus Arteriosus (PDA). • ...

No FAQ available that match "truncus arteriosus persistent"

No images available that match "truncus arteriosus persistent"